Contact

All Stories

  1. What are the important barriers to recruitment in randomised clinical studies?

    Article • Trials, October 2019, Springer Science + Business Media

    Associate Professor Erik Lundström

  2. Fluoxetine for stroke recovery: Meta-analysis of randomized controlled trials

    Article • International Journal of Stroke, October 2019, SAGE Publications

    Associate Professor Erik Lundström

  3. Fluoxetine - a common antidepressant medication - seems to increase the risk for fractures in stroke

    Article • Stroke, August 2019, Wolters Kluwer Health

    Associate Professor Erik Lundström

  4. Effects of fluoxetine on functional outcomes after acute stroke (FOCUS): a pragmatic, double-blind, randomised, controlled trial

    Article • The Lancet, January 2019, Elsevier

    Associate Professor Erik Lundström, Professor Malcolm R Macleod, Frank Sullivan

  5. Trends in diagnosis-specific work disability before and after ischaemic heart disease: a nationwide population-based cohort study in Sweden

    Article • BMJ Open, April 2018, BMJ

    Associate Professor Erik Lundström

  6. Long-term health-related quality of life, survival and costs by different levels of functional outcome six months after stroke

    Article • European Stroke Journal, January 2018, SAGE Publications

    Ann-Sofie Rudberg, Associate Professor Erik Lundström

  7. Enhancing Recruitment Using Teleconference and Commitment Contract (ERUTECC): study protocol for a randomised, stepped-wedge cluster trial within the EFFECTS trial

    Article • Trials, January 2018, Springer Science + Business Media

    Associate Professor Erik Lundström

  8. Trends in Diagnosis‐Specific Work Disability Before and After Stroke: A Longitudinal Population‐Based Study in Sweden

    Article • Journal of the American Heart Association, January 2018, Wolters Kluwer Health

    Associate Professor Erik Lundström

  9. The FOCUS, AFFINITY and EFFECTS trials studying the effect(s) of fluoxetine in patients with a recent stroke: statistical and health economic analysis plan for the trials and for the individual patient data meta-analysis

    Article • Trials, December 2017, Springer Science + Business Media

    Associate Professor Erik Lundström

  10. Validation of Serial Alberta Stroke Program Early CT Score as an Outcome Predictor in Thrombolyzed Stroke Patients

    Article • Journal of Stroke and Cerebrovascular Diseases, October 2017, Elsevier

    Associate Professor Erik Lundström

  11. Permanent work disability before and after ischaemic heart disease or stroke event: a nationwide population-based cohort study in Sweden

    Article • BMJ Open, September 2017, BMJ

    Associate Professor Erik Lundström

  12. Nongated Cardiac Computed Tomographic Angiograms for Detection of Embolic Sources in Acute Ischemic Stroke

    Article • Stroke, May 2017, Wolters Kluwer Health

    Associate Professor Erik Lundström

  13. Work disability before and after a major cardiovascular event: a ten-year study using nationwide medical and insurance registers

    Article • Scientific Reports, April 2017, Springer Science + Business Media

    Associate Professor Erik Lundström

  14. Recommendations from the ESO-Karolinska Stroke Update Conference, Stockholm 13–15 November 2016

    Article • European Stroke Journal, March 2017, SAGE Publications

    Associate Professor Erik Lundström

  15. Synchronous cardiocerebral infarction in the era of endovascular therapy: which to treat first?

    Article • Journal of Thrombosis and Thrombolysis, February 2017, Springer Science + Business Media

    Associate Professor Erik Lundström

  16. Effects of alteplase on survival after ischaemic stroke (IST-3): 3 year follow-up of a randomised, controlled, open-label trial

    Article • The Lancet Neurology, September 2016, Elsevier

    Associate Professor Erik Lundström

  17. Predicting return to work after subarachnoid hemorrhage using the Montreal Cognitive Assessment (MoCA)

    Article • Acta Neurochirurgica, December 2015, Springer Science + Business Media

    Associate Professor Erik Lundström

  18. How common is isolated dysphasia among patients with stroke treated with intravenous thrombolysis, and what is their outcome? Results from the SITS-ISTR

    Article • BMJ Open, November 2015, BMJ

    Associate Professor Erik Lundström

  19. The FOCUS, AFFINITY and EFFECTS trials studying the effect(s) of fluoxetine in patients with a recent stroke: a study protocol for three multicentre randomised controlled trials

    Article • Trials, August 2015, Springer Science + Business Media

    Associate Professor Erik Lundström

  20. Attention Deficits After Aneurysmal Subarachnoid Hemorrhage Measured Using the Test of Variables of Attention

    Article • Stroke, March 2015, Wolters Kluwer Health

    Associate Professor Erik Lundström

  21. Establishing the effect(s) and safety of Fluoxetine initiated in the acute phase of stroke

    Article • December 2014, Springer Science + Business Media

    Associate Professor Erik Lundström

  22. Prevalence of spasticity after aneurysmal subarachnoid haemorrhage

    Article • Journal of Rehabilitation Medicine, January 2014, Acta Dermato-Venereologica

    Associate Professor Erik Lundström

  23. Agreement between ambulance nurses and physicians in assessing stroke patients

    Article • Acta Neurologica Scandinavica, May 2013, Wiley

    Associate Professor Erik Lundström

  24. Letter by Mead et al Regarding Article, "Selective Serotonin Reuptake Inhibitors for Stroke: More Trials are Needed"

    Article • Stroke, April 2013, Wolters Kluwer Health

    Associate Professor Erik Lundström

  25. Health-related quality of life at median 12 months after aneurysmal subarachnoid hemorrhage, measured with EuroQoL-5D

    Article • Acta Neurochirurgica, January 2013, Springer Science + Business Media

    Associate Professor Erik Lundström

  26. Migrainous Infarction: Aspects on Risk Factors and Therapy

    Article • Current Pain and Headache Reports, April 2012, Springer Science + Business Media

    Associate Professor Erik Lundström

  27. Update on the third international stroke trial (IST-3) of thrombolysis for acute ischaemic stroke and baseline features of the 3035 patients recruited

    Article • Trials, November 2011, Springer Science + Business Media

    Professor Malcolm R Macleod, Associate Professor Erik Lundström

  28. Outcome After Spontaneous Subarachnoid Hemorrhage Measured With the EQ-5D

    Article • Stroke, November 2011, Wolters Kluwer Health

    Associate Professor Erik Lundström

  29. Response to Letter by Dobkin

    Article • Stroke, July 2010, Wolters Kluwer Health

    Associate Professor Erik Lundström

  30. International Comparisons of Stroke Costs Are Always Limited

    Article • Stroke, July 2010, Wolters Kluwer Health

    Associate Professor Erik Lundström

  31. Four-Fold Increase in Direct Costs of Stroke Survivors With Spasticity Compared With Stroke Survivors Without Spasticity

    Article • Stroke, February 2010, Wolters Kluwer Health

    Associate Professor Erik Lundström

  32. Time-course and determinants of spasticity during the first six months following first-ever stroke

    Article • Journal of Rehabilitation Medicine, January 2010, Acta Dermato-Venereologica

    Associate Professor Erik Lundström

  33. Risk factors for stroke-related pain 1 year after first-ever stroke

    Article • European Journal of Neurology, February 2009, Wiley

    Associate Professor Erik Lundström

  34. How common is disabling spasticity one year after first-ever stroke?

    Article • European Journal of Neurology, June 2008, Wiley

    Associate Professor Erik Lundström

  35. Objective assessment of cervical dystonia: a pilot study

    Article • Acta Neurologica Scandinavica, October 2005, Wiley

    Associate Professor Erik Lundström